Everyone has web access to product design plan, and is given the opportunity to contribute to it. In case of clinical stages of drug development the "product" is an executable clinical development plan and / or clinical study protocol.
This paradigm has proven very successful in the software industry (most likely you are currently using at least one major software product which was open source designed: Linux, etc), and in many other sectors of the economy. Although a lot of lip service has been given to the concept by the pharma / biotech sector it did not truly move beyond discussion stages.
To find more:
http://en.wikipedia.org/wiki/Open_source
No comments:
Post a Comment